Radiofrequency ablation in liver tumours

Annals of Oncology

Volumn 15, Issue SUPPL. 4, 2004, Pages

  Benoist, S ^a   Nordlinger, B ^a  

^a HÔPITAL AMBROISE PARÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ABDOMINAL BLEEDING; ABDOMINAL DISCOMFORT; ARTICLE; BILE DUCT INJURY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CATHETER ABLATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ELECTRODE; FEVER; FOLLOW UP; HEART DISEASE; HEMOPERITONEUM; HUMAN; IATROGENIC DISEASE; LAPAROSCOPY; LAPAROTOMY; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER METASTASIS; META ANALYSIS; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PLEURA EFFUSION; PRIORITY JOURNAL; RISK FACTOR; THERMAL INJURY; TISSUE PERFUSION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; MORBIDITY;

EID: 9744230598     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh945     Document Type: Article

References (44)

1. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 745-750.
2. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343: 1405-1410.
3. Nordlinger B, Guiguet M, Vaillant J-C et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Cancer 1996; 77: 1254-1262.
4. Poon RT, Fan ST, Lo CM et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001; 234: 63-70.
5. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg 1990; 211: 277-287.
6. Nordlinger B, Benoist S. Treatment options for metastatic liver cancer. Surgical resection including perioperative chemotherapy (adjuvant and neoadjuvant). Eur J Cancer 2003; 1: 181-188.
7. Ruers TJM. Tumour ablative procedures for colorectal livers metastases. Eur J Cancer 2003; 1: 189-199.
8. Erce C, Parks W. Interstitial ablative techniques for hepatic tumours. Br J Surg 2003; 90: 272-289.
9. Pawlik TM, Izzo F, Cohen DS et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003; 10: 1059-1069.
10. Mutsaerts EL, Van Coevorden F, Krause R et al. Initial experience with radiofrequency ablation for hepatic tumours in The Netherlands. Eur J Surg Oncol 2003; 29: 731-734.
11. Garcea G, Lloyd TD, Aylott C et al. The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. Eur J Cancer 2003; 39: 2150-2164.
12. Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepatocellular carcinoma: a review and look into the future. Ann Surg 2003; 237: 171-179.
13. Curley SA. Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol 2003; 10: 338-347.
14. Curley SA, Izzo F, Ellis LM et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000; 232: 381-391.
15. Bleicher RJ, Allegra DP, Nora DT et al. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003; 10: 52-58.
16. Gillams AR. Radiofrequency ablation in the management of liver tumours. Eur J Surg Oncol 2003; 29: 9-16.
17. Denys AL, De Baere T, Kuoch V et al. Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems. Eur Radiol 2003; 13: 2346-2352.
18. Curley SA, Izzo F, Delrio P et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999; 230: 1-8.
19. de Baere T, Bessoud B, Dromain C et al. Percutaneous radiofrequency ablation of hepatic tumors during temporary venous occlusion. Am J Roentgenol 2002; 178: 53-59.
20. Solbiati L, Livraghi T, Goldberg SN et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001; 221: 159-166.
21. Livraghi T, Goldberg SN, Lazzaroni S et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology 2000; 214: 761-768.
22. Dodd GD, Frank MS, Aribandi M et al. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. Am J Roentgenol 2001; 177: 777-782.
23. Santambrogio R, Podda M, Zuin M et al. Safety and efficacy of laparoscopic radiofrequency of hepatocellular carcinoma in patients with liver cirrhosis. Surg Endosc 2003; 17: 1826-1832.
24. Oshowo A, Gillams AR, Lees WR, Taylor I. Radiofrequency ablation extends the scope of surgery in colorectal liver metastases. Eur J Surg Oncol 2003; 29: 244-247.
25. Ruers TJ, Langenhoff BS, Neeleman N et al. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 2002; 20: 388-395.
26. Mulier S, Mulier P, Ni Y et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002; 89: 1206-1222.
27. de Baere T, Risse O, Kuoch V et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. Am J Roentgenol 2003; 181: 695-700.
28. Qian J, Feng GS, Vogl T. Combined interventional therapies of hepatocellular carcinoma. World J Gastroenterol 2003; 9: 1885-1891.
29. Livraghi T, Solbiati L, Meloni MF et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226: 441-451.
30. Bolondi L, Piscaglia F, Camaggi V et al. Liver transplantation for HCC. Treatment options on the waiting list. Aliment Pharmacol Ther 2003; 17: 145-150.
31. Rossi S, Di Stasi M, Buscarini E et al. Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. Am J Roentgenol 1996; 167: 759-768.
32. Buscarini L, Buscarini E, Di Stasi M et al. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001; 11: 914-921.
33. Chan RP, Asch M, Kachura J et al. Radiofrequency ablation of malignant hepatic neoplasms. Can Assoc Radiol J 2002; 53: 272-278.
34. Lencioni RA, Allgaier HP, Cioni D et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003; 228: 235-240.
35. Harrison LE, Koneru B, Baramipour P et al. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg 2003; 197: 759-764.
36. Guglielmi A, Ruzzenente A, Battocchia A et al. Radiofrequency ablation of hepatocellular carcinoma in cirrhotic patients. Hepatogastroenterology 2003; 50: 480-484.
37. Livraghi T, Goldberg N, Lazzaroni S et al. Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 1999; 210: 655-661.
38. Olschewski M, Lencioni R, Allgaier H et al. A randomized comparison of radio-frequency thermal ablation and percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Proc Am Soc Clin Oncol 2001; 20: 126a (Abstr 500).
39. Lin SM, Lin CJ, Hsu CW et al. Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors. Cancer 2004; 100: 376-382.
40. Elias D, De Baere T, Smayra T et al. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg 2002; 89: 752-756.
41. Wood TF, Rose DM, Chung M et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000; 7: 593-600.
42. de Baere T, Elias D, Dromain C et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. Am J Roentgenol 2000; 175: 1619-1625.
43. Gillams AR, Lees WR. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 2000; 43: 656-661.
44. Bowles BJ, Machi J, Limm WM et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001; 136: 864-869.